pharmaphorum

OCTOBER 12, 2022

David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. Having spent 10 years working in the genomics field, Del Bourgo noticed manufacturers spending extensive resources on drug development without harnessing the transformative power of data.

Medicine 89

Medicine Patients Healthcare Healthcare 89

Pharmaceutical Technology

NOVEMBER 9, 2022

They are inextricably linked: data cannot be interpreted without cutting-edge algorithms, and algorithms cannot draw precise conclusions without data of sufficient quality and quantity. The Covid-19 pandemic increased the urgency of harnessing the power of novel technology. what it means for you.

Pharmaceutical 52

Pharmaceutical Distribution Pharma Manufacturing 52

Spotio

FEBRUARY 20, 2023

Thanks to the rising cost of energy, manufacturing cost reductions, and solar-friendly legislation in many countries worldwide, experts expect a 40% jump in solar installations over the next few years. Doing so will give you the edge to take full advantage of the current industry growth. And more significant growth is on the horizon.

Management 52

Management Prospecting Sales pitches Sales 52

European Pharmaceutical Review

SEPTEMBER 20, 2023

Although this evolution has led to life-changing medications, it also calls on drug development and manufacturing experts to identify new, more efficient ways to deliver high‑quality products. Pharmaceutical development is driven by quality by design (QbD) – an approach recommended by regulatory agencies. Where now with quality by design?

Patients 86

Patients Manufacturing Leads Safety 86

Evolve Your Success

DECEMBER 20, 2022

Hank joins host Samuel Adeyinka to share the journey he’s taken to discover his path in the industry. Hank joins host Samuel Adeyinka to share the journey he’s taken to discover his path in the industry. Meet Hank Balch , a man who started his career in instrument reprocessing as a frontline technician. — Watch the episode here.

Medical sales 52

Medical sales Media Sales Medical sales reps 52

Pharmaceutical Technology

JUNE 26, 2022

As every molecule and development program is unique, there is no single drug substance synthesis and manufacturing solution, so understanding what processes and technologies are available, what strategy is best, and who to partner with is key. . Important considerations for drug substance development.

Manufacturing 52

Manufacturing Leads Medicine Pharmaceutical 52

Pharmaceutical Technology

APRIL 16, 2023

The question now is how to best design and manufacture autoinjectors that can be used to safely store and administer these larger volumes. Autoinjectors have revolutionised the convenient delivery of low-volume parenteral drugs. Traditionally, autoinjector combination products have been limited to injection volumes of 0.1 autoinjector.

Medical 52

Medical Medicine Patients Manufacturing 52